Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy

X Zhang, C He, G Xiang - Cancer Letters, 2022 - Elsevier
Abstract Hypoxia-inducible factor-1 (HIF-1), an essential promoter of tumor progression, has
attracted increasing attention as a therapeutic target. In addition to hypoxic cellular …

Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact

K Doege, S Heine, I Jensen, W Jelkmann, E Metzen - Blood, 2005 - ashpublications.org
The transcription factor hypoxia-inducible factor-1 (HIF-1) is critical for erythropoietin and
other factors involved in the adaptation of the organism to hypoxic stress. Conflicting results …

Redox signaling pathways involved in neuronal ischemic preconditioning

JW Thompson, SV Narayanan… - Current …, 2012 - ingentaconnect.com
There is extensive evidence that the restoration of blood flow following cerebral ischemia
contributes greatly to the pathophysiology of ischemia mediated brain injury. The initiating …

[HTML][HTML] Nitric oxide favours tumour-promoting inflammation through mitochondria-dependent and-independent actions on macrophages

D Drehmer, JPM Luiz, CAS Hernandez, JC Alves-Filho… - Redox biology, 2022 - Elsevier
Production of nitric oxide (NO) has been demonstrated in several malignancies, however its
role remains not fully understood, specifically in relation to the metabolic and functional …

Improved hepatoprotective effect of liposome-encapsulated astaxanthin in lipopolysaccharide-induced acute hepatotoxicity

CH Chiu, CC Chang, ST Lin, CC Chyau… - International journal of …, 2016 - mdpi.com
Lipopolysaccharide (LPS)-induced acute hepatotoxicity is significantly associated with
oxidative stress. Astaxanthin (AST), a xanthophyll carotenoid, is well known for its potent …

Chemosensitization of cancer by nitric oxide

R Sullivan, CH Graham - Current pharmaceutical design, 2008 - ingentaconnect.com
Recent evidence from experimental and clinical studies links the development of
intratumoral hypoxia and oxidative stress with malignant progression. Cellular adaptation …

Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1α in cancer: role of free radical formation

M Quintero, PA Brennan, GJ Thomas, S Moncada - Cancer research, 2006 - AACR
Widespread expression of the α-subunit of hypoxia-inducible factor (HIF-1α) was observed
in samples of human oral squamous cell carcinoma. In all the cases, this was accompanied …

Hydrogen sulfide inhibits hypoxia-but not anoxia-induced hypoxia-inducible factor 1 activation in a von hippel-lindau-and mitochondria-dependent manner

S Kai, T Tanaka, H Daijo, H Harada… - Antioxidants & redox …, 2012 - liebertpub.com
Aims: In addition to nitric oxide and carbon monoxide, hydrogen sulfide (H2S) is an
endogenously synthesized gaseous molecule that acts as an important signaling molecule …

Hypoxia inducible factor-1α in osteochondral tissue engineering

DK Taheem, G Jell, E Gentleman - Tissue Engineering Part B …, 2020 - liebertpub.com
Damage to osteochondral (OC) tissues can lead to pain, loss of motility, and progress to
osteoarthritis. Tissue engineering approaches offer the possibility of replacing damaged …

NFE2L2/NRF2 activity is linked to mitochondria and AMP-activated protein kinase signaling in cancers through miR-181c/mitochondria-encoded cytochrome c …

KA Jung, S Lee, MK Kwak - Antioxidants & Redox Signaling, 2017 - liebertpub.com
Aims: The nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NFE2L2/NRF2) pathway
contributes to the environmental resistance of cancers by enhancing the antioxidant …